Article Details

Lilly says diabetes shot outperformed rival Novo drug in study

Retrieved on: 2021-03-04 17:15:00

Tags for this article:

Click the tags to see associated articles and topics

Lilly says diabetes shot outperformed rival Novo drug in study. View article details on HISWAI: https://www.biopharmadive.com/news/eli-lilly-tirzepatide-diabetes-novo-nordisk/596155/

Excerpt

Trulicity is the Indiana-based company's top-seller, but will lose patent protection in 2027. Recommended Reading: BioPharma Dive Lilly reports strong ...

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up